Fumi Takemoto

2.8k total citations
107 papers, 2.1k citations indexed

About

Fumi Takemoto is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fumi Takemoto has authored 107 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Nephrology, 37 papers in Molecular Biology and 35 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fumi Takemoto's work include Renal Diseases and Glomerulopathies (21 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers) and Parathyroid Disorders and Treatments (13 papers). Fumi Takemoto is often cited by papers focused on Renal Diseases and Glomerulopathies (21 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers) and Parathyroid Disorders and Treatments (13 papers). Fumi Takemoto collaborates with scholars based in Japan and United States. Fumi Takemoto's co-authors include Yoshifumi Ubara, Kenmei Takaichi, Keitaro Yokoyama, Akira Yamada, Shigeko Hara, Naoki Sawa, Hideyuki Katori, Junichi Hoshino, Yoshiaki Kawaguchi and Shunya Uchida and has published in prestigious journals such as Journal of Clinical Investigation, Biochemical and Biophysical Research Communications and Kidney International.

In The Last Decade

Fumi Takemoto

103 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumi Takemoto Japan 24 568 497 496 474 455 107 2.1k
A. Testa Italy 26 330 0.6× 609 1.2× 342 0.7× 427 0.9× 285 0.6× 86 2.1k
Ashio Yoshimura Japan 23 730 1.3× 1.3k 2.7× 528 1.1× 378 0.8× 222 0.5× 75 2.7k
Hideki Tahara Japan 28 466 0.8× 1.1k 2.3× 767 1.5× 333 0.7× 579 1.3× 75 3.3k
Yusuf Oğuz Türkiye 30 288 0.5× 952 1.9× 533 1.1× 303 0.6× 267 0.6× 54 2.4k
U. Helmchen Germany 22 357 0.6× 745 1.5× 476 1.0× 598 1.3× 263 0.6× 65 2.2k
Sharon Silbiger United States 24 510 0.9× 893 1.8× 393 0.8× 301 0.6× 148 0.3× 33 2.6k
Takami Miki Japan 17 582 1.0× 745 1.5× 374 0.8× 270 0.6× 165 0.4× 55 2.4k
Elvira Fernández Spain 27 356 0.6× 1.1k 2.3× 451 0.9× 527 1.1× 139 0.3× 74 2.3k
Tracy E. Hunley United States 23 455 0.8× 560 1.1× 446 0.9× 254 0.5× 217 0.5× 45 1.7k
Harald S. Mackenzie United States 29 1.0k 1.8× 932 1.9× 568 1.1× 522 1.1× 224 0.5× 51 3.8k

Countries citing papers authored by Fumi Takemoto

Since Specialization
Citations

This map shows the geographic impact of Fumi Takemoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumi Takemoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumi Takemoto more than expected).

Fields of papers citing papers by Fumi Takemoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumi Takemoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumi Takemoto. The network helps show where Fumi Takemoto may publish in the future.

Co-authorship network of co-authors of Fumi Takemoto

This figure shows the co-authorship network connecting the top 25 collaborators of Fumi Takemoto. A scholar is included among the top collaborators of Fumi Takemoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumi Takemoto. Fumi Takemoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akimoto, Tetsu, Yoshitaka Iwazu, Akihiko Numata, et al.. (2014). Henoch–Schönlein purpura complicated with severe gastrointestinal bleeding. CEN Case Reports. 4(1). 106–111. 10 indexed citations
2.
Akimoto, Tetsu, Akihiko Numata, Yoshiyuki Morishita, et al.. (2014). Purpura with Ulcerative Skin Lesions and Mixed Cryoglobulinemia in a Quiescent Hepatitis B Virus Carrier. Internal Medicine. 53(2). 115–119. 13 indexed citations
3.
Morishita, Yoshiyuki, Manabu Ogura, Chiharu Ito, et al.. (2012). A Case of Diffuse Endocapillary Proliferative Glomerulonephritis Associated with Polymyalgia Rheumatica. PubMed. 2(2). 158–164. 1 indexed citations
4.
Tsuchiya, Yoshiki, Yoshifumi Ubara, Tatsuya Suwabe, et al.. (2011). Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis. Clinical and Experimental Nephrology. 15(3). 434–437. 6 indexed citations
5.
Tsuchiya, Yoshiki, Yoshifumi Ubara, Tatsuya Suwabe, et al.. (2010). The renal cyst infection caused by Salmonella enteritidis in a patient with autosomal dominant polycystic kidney disease: how did this pathogen come into the renal cysts?. Clinical and Experimental Nephrology. 15(1). 151–153. 5 indexed citations
6.
Suwabe, Tatsuya, Yoshifumi Ubara, Shohei Nakanishi, et al.. (2009). Infected Hepatic and Renal Cysts: Differential Impact on Outcome in Autosomal Dominant Polycystic Kidney Disease. Nephron Clinical Practice. 112(3). c157–c163. 27 indexed citations
7.
Takemoto, Fumi, Hideyuki Katori, Naoki Sawa, et al.. (2008). Plasma Adiponectin: A Predictor of Coronary Heart Disease in Hemodialysis Patients – A Japanese Prospective Eight-Year Study. Nephron Clinical Practice. 111(1). c12–c20. 15 indexed citations
8.
9.
Takemoto, Fumi, Hideyuki Katori, Junichi Hoshino, et al.. (2007). Induction of Anti-Carbonic-Anhydrase-II Antibody Causes Renal Tubular Acidosis in a Mouse Model of Sjögren’s Syndrome. Nephron Physiology. 106(4). p63–p68. 39 indexed citations
10.
Ubara, Yoshifumi, Tetsuo Tagami, Tatsuya Suwabe, et al.. (2005). Pelvic Insufficiency Fracture Related to Autosomal Dominant Polycystic Kidney Disease. American Journal of Kidney Diseases. 46(6). e103–e111. 6 indexed citations
11.
Ubara, Yoshifumi, Tetsuo Tagami, Tatsuya Suwabe, et al.. (2005). A patient with symptomatic osteomalacia associated with Fanconi syndrome. Modern Rheumatology. 15(3). 207–212. 4 indexed citations
12.
Ubara, Yoshifumi, Tetsuo Tagami, Naoki Sawa, et al.. (2005). Significance of minimodeling in dialysis patients with adynamic bone disease. Kidney International. 68(2). 833–839. 34 indexed citations
13.
Ohshima, M, Yoshifumi Ubara, Tetsuo Tagami, et al.. (2005). Long‐term Erythropoietin Therapy Improves Response in Myelodysplastic Syndrome. Therapeutic Apheresis and Dialysis. 9(4). 362–366. 1 indexed citations
14.
Hoshino, Junichi, Shigeo Hara, Yoshifumi Ubara, et al.. (2005). Distribution of IgG subclasses in a biopsy specimen showing membranous nephropathy with anti-glomerular basement membrane glomerulonephritis: An uncharacteristically good outcome with corticosteroid therapy. American Journal of Kidney Diseases. 45(4). e67–e72. 7 indexed citations
15.
Takemoto, Fumi, Toshimasa Shinki, Keitaro Yokoyama, et al.. (2003). Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats. Kidney International. 64(2). 414–420. 63 indexed citations
16.
Hoshino, Junichi, Yoshifumi Ubara, Tetsuo Tagami, et al.. (2003). Chinese Herbs and Bone Disease. Internal Medicine. 42(4). 345–350. 2 indexed citations
17.
Ubara, Yoshifumi, Tetsuo Tagami, Naoki Sawa, et al.. (2002). Renal contraction therapy for enlarged polycystic kidneys by transcatheter arterial embolization in hemodialysis patients. American Journal of Kidney Diseases. 39(3). 571–579. 62 indexed citations
18.
Ubara, Yoshifumi, Tetsuo Tagami, Hideyuki Katori, et al.. (2000). Establishment of linkage analysis strategy for autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation. 15(9). 62. 1 indexed citations
19.
Ubara, Yoshifumi, Hideyuki Katori, Tetsuo Tagami, et al.. (1999). Transcatheter renal arterial embolization therapy on a patient with polycystic kidney disease on hemodialysis. American Journal of Kidney Diseases. 34(5). 926–931. 28 indexed citations
20.
Uchida, Shunya, Fumi Takemoto, Etsuro Ogata, & Kiyoshi Kurokawa. (1993). Endothelin-1 and -3 Binding to ETB Receptors in Rat Renal Tubules. Journal of Cardiovascular Pharmacology. 22(Supplement 8). S177–S180. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Testa Breakdown of academic impact, for papers by Ashio Yoshimura Breakdown of academic impact, for papers by Hideki Tahara Breakdown of academic impact, for papers by Yusuf Oğuz Breakdown of academic impact, for papers by U. Helmchen Breakdown of academic impact, for papers by Sharon Silbiger Breakdown of academic impact, for papers by Takami Miki Breakdown of academic impact, for papers by Elvira Fernández Breakdown of academic impact, for papers by Tracy E. Hunley Breakdown of academic impact, for papers by Harald S. Mackenzie
Rankless by CCL
2026